https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:85 12, propionic acid, folacin and bacteriocins by probiotic strains, stimulation of bifidobacteria growth, production of favourable effects on the lipid metabolism and on the immune system of hosts through immunostimulation, immunomodulation or use of a probiotic strain as an adjuvant, reduction of homocysteine and beta glucuronidase and the prevention, treatment or amelioration of conditions associated with a need for these activities. The probiotic bacteria of the invention can be used in humans or other animals. In at least some applications, the bacteria can be used dead and parts rather than whole cells may be used. The present invention also relates to the preparation of vaccines for use in protecting patients from infectious diseases, in particular tuberculosis.]]> Thu 25 Jul 2013 09:10:11 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:481 Thu 25 Jul 2013 09:09:52 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:124 Thu 25 Jul 2013 09:09:42 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:102 Thu 25 Jul 2013 09:09:37 AEST ]]>